stocks logo

SNTI Valuation

Senti Biosciences Inc
$
3.220
-0.020(-0.620%)
  • Overview
  • Forecast
  • Valuation

SNTI Relative Valuation

SNTI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SNTI is overvalued; if below, it's undervalued.

Historical Valuation

No Data

Competitors Valuation Multiple

The average P/S ratio for SNTI's competitors is 10.83, providing a benchmark for relative valuation. Senti Biosciences Inc Corp (SNTI) exhibits a P/S ratio of 16.38, which is 51.18% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

FAQ

arrow icon

Is Senti Biosciences Inc (SNTI) currently overvalued or undervalued?

Senti Biosciences Inc (SNTI) is now in the Overvalued zone, suggesting that its current forward PS ratio of 16.38 is considered Overvalued compared with the five-year average of 13.87. The fair price of Senti Biosciences Inc (SNTI) is between 0.57 to 2.44 according to relative valuation methord. Compared to the current price of 3.22 USD , Senti Biosciences Inc is Overvalued By 31.70% .
arrow icon

What is Senti Biosciences Inc (SNTI) fair value?

arrow icon

How does SNTI's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Senti Biosciences Inc (SNTI) as of May 20 2025?

arrow icon

What is the current FCF Yield for Senti Biosciences Inc (SNTI) as of May 20 2025?

arrow icon

What is the current Forward P/E ratio for Senti Biosciences Inc (SNTI) as of May 20 2025?

arrow icon

What is the current Forward P/S ratio for Senti Biosciences Inc (SNTI) as of May 20 2025?